These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27038357)

  • 1. Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.
    Ali MS; Groenwold RH; Belitser SV; Souverein PC; Martín E; Gatto NM; Huerta C; Gardarsdottir H; Roes KC; Hoes AW; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():114-21. PubMed ID: 27038357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture.
    Uddin MJ; Groenwold RH; de Boer A; Gardarsdottir H; Martin E; Candore G; Belitser SV; Hoes AW; Roes KC; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():122-31. PubMed ID: 27038358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.
    Souverein PC; Abbing-Karahagopian V; Martin E; Huerta C; de Abajo F; Leufkens HG; Candore G; Alvarez Y; Slattery J; Miret M; Requena G; Gil MJ; Groenwold RH; Reynolds R; Schlienger RG; Logie JW; de Groot MC; Klungel OH; van Staa TP; Egberts TC; De Bruin ML; Gardarsdottir H
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():88-102. PubMed ID: 27038355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project.
    Requena G; Huerta C; Gardarsdottir H; Logie J; González-González R; Abbing-Karahagopian V; Miret M; Schneider C; Souverein PC; Webb D; Afonso A; Boudiaf N; Martin E; Oliva B; Alvarez A; De Groot MC; Bate A; Johansson S; Schlienger R; Reynolds R; Klungel OH; de Abajo FJ
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():66-78. PubMed ID: 26100105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent propensity score and collider-stratification bias: an example of beta2-agonist use and the risk of coronary heart disease.
    Sanni Ali M; Groenwold RH; Pestman WR; Belitser SV; Hoes AW; de Boer A; Klungel OH
    Eur J Epidemiol; 2013 Apr; 28(4):291-9. PubMed ID: 23354982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.
    Bakken MS; Engeland A; Engesæter LB; Ranhoff AH; Hunskaar S; Ruths S
    Age Ageing; 2013 Jul; 42(4):514-20. PubMed ID: 23438446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain.
    Maciá-Martínez MA; Gil M; Huerta C; Martín-Merino E; Álvarez A; Bryant V; Montero D;
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1236-1245. PubMed ID: 32337840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.
    Patrick AR; Schneeweiss S; Brookhart MA; Glynn RJ; Rothman KJ; Avorn J; Stürmer T
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):551-9. PubMed ID: 21394812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
    Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
    JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.
    Vangala C; Niu J; Montez-Rath ME; Yan J; Navaneethan SD; Winkelmayer WC
    Am J Kidney Dis; 2020 Mar; 75(3):351-360. PubMed ID: 31606233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
    Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
    Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
    Huybrechts KF; Bateman BT; Palmsten K; Desai RJ; Patorno E; Gopalakrishnan C; Levin R; Mogun H; Hernandez-Diaz S
    JAMA; 2015 Jun; 313(21):2142-51. PubMed ID: 26034955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-only designs for studying the association of antidepressants and hip or femur fracture.
    de Groot MC; Candore G; Uddin MJ; Souverein PC; Ali MS; Belitser SV; Huerta C; Groenwold RH; Alvarez Y; Slattery J; Korevaar J; Hoes AW; Roes KC; de Boer A; Douglas IJ; Schlienger RG; Reynolds R; Klungel OH; Gardarsdottir H
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():103-13. PubMed ID: 27038356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and fracture risk in older adults: a comparative safety analysis.
    Gagne JJ; Patrick AR; Mogun H; Solomon DH
    Clin Pharmacol Ther; 2011 Jun; 89(6):880-7. PubMed ID: 21508938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.
    Hubbard R; Farrington P; Smith C; Smeeth L; Tattersfield A
    Am J Epidemiol; 2003 Jul; 158(1):77-84. PubMed ID: 12835289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of dementia among antidepressant elderly users: A population-based cohort analysis in Spain.
    Santandreu J; Caballero FF; Gómez-Serranillos MP; González-Burgos E
    J Affect Disord; 2024 Mar; 349():54-61. PubMed ID: 38195007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.